INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
93 hedge funds and large institutions have $38.6M invested in Infinity Pharmaceuticals, Inc. in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 37 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-4
Holders Change %
-4.12%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
37
Closed
15
Calls
$471K
Puts
$107K
Net Calls
+$364K
Net Calls Change
-$1.86M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$674K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$319K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$300K |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$174K |
| 5 |
Morgan Stanley
New York
|
+$168K |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.73M |
| 2 |
Millennium Management
New York
|
-$786K |
| 3 |
D.E. Shaw & Co
New York
|
-$529K |
| 4 |
CC
Callan Capital
La Jolla,
California
|
-$329K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$323K |
